Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

WELL Health Technologies Corp WHTCF


Primary Symbol: T.WELL Alternate Symbol(s):  T.WELL.DB

WELL Health Technologies Corp. is a practitioner-focused digital healthcare company. The Company develops technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. Its business units include Canadian Patient Services, WELL Health USA Patient Services and SaaS and Technology Services. WELL Health USA Patient and Provider Services includes Primary Circle Medical, Primary WISP, Specialized CRH Medical, and Specialized Provider Staffing. Its healthcare and digital platform includes front and back-office management software applications that help physicians run and secure their practices. Its focused markets include the gastrointestinal market, women's health, primary care and mental health. Its solutions enable 34,000 healthcare providers between the United States and Canada and power owned and operated healthcare’s in Canada with 165 clinics supporting primary care, specialized care and diagnostic services.


TSX:WELL - Post by User

Post by retiredcfon Sep 11, 2023 11:00am
233 Views
Post# 35629335

Morgan Stanley

Morgan Stanley

Morgan Stanley chief U.S. equity strategist Michael Wilson stays adamantly bearish and believes markets are beginning to show typical late cycle behaviour,

“We view this year as an extension of the late cycle period often experienced when the Fed is expected to pause or reverse its hawkish policy stance. As is typical in such periods, multiple expansion has moved ahead of where macro fundamentals dictate fair value to be, placing the burden on a growth reacceleration and/or incremental policy support that’s not already in the price in order to keep multiples elevated … Late cycle/more conservative factors are outperforming once again. Specifically, we note that high cash, low debt and low capex factors have performed well over the last month; long term growth and strong sales/earnings revisions factors are also working. Interestingly, despite the rate move higher since the local peak in equities in late July, growth has outpaced both value and cyclicals. Further, a broad set of early cycle winners have seen relative underperformance recently. In our view, this supports our preference for a late cycle playbook. Overweight Health Care...Health Care has underperformed the market year-to-date but is showing relative strength against other defensive pockets”

<< Previous
Bullboard Posts
Next >>